Actinium Pharmaceuticals, Inc. (ATNM)
1.32
-0.01
(-0.75%)
USD |
NYAM |
Jan 15, 11:11
Actinium Pharmaceuticals SG&A Expense (TTM): 15.79M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arcus Biosciences, Inc. | 112.00M |
| Apyx Medical Corp. | 22.16M |
| AbbVie, Inc. | 13.97B |
| Karyopharm Therapeutics, Inc. | 109.63M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |